Utilization of preoperative endoscopic ultrasound for pancreatic adenocarcinoma.
Schmocker, Ryan K; Vanness, David J; Greenberg, Caprice C; Havlena, Jeff A; LoConte, Noelle K; Weiss, Jennifer M; Neuman, Heather B; Leverson, Glen; Smith, Maureen A; Winslow, Emily R.
; 19(5): 465-472, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28237627
A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion.
Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.
TGF-ß Tumor Suppression through a Lethal EMT.
Neoadjuvant and adjuvant chemotherapy in pancreatic cancer.
Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.
[A Case of Long-Term Survival after Total Pancreatectomy for Recurrent Pancreatic Cancer in the Remnant Pancreas after Pancreatoduodenectomy].
Tumor Heterogeneity in Pancreatic Adenocarcinoma.
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer.